Rezolute to announce DMC conclusions in April, says H.C. Wainwright
Rezolute (RZLT) announced that the independent data monitoring committee reviewed safety and pharmacokinetics in eight infant patients in the ...
JMP Securities lifts Rezolute stock target to $9, maintains rating
JMP Securities adjusted its financial outlook for Rezolute (NASDAQ:RZLT), increasing the price target to $9.00 from the previous $8.00, while keeping a Market Outperform rating on the stock. Currently ...
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...
Rezolute Insiders Placed Bullish Bets Worth US$557.5k
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.C79yHELW.js ...
Rezolute’s (RZLT) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Rezolute (NASDAQ:RZLT – Free Report) in a report published on Wednesday morning,Benzinga reports. The firm currently has a $14.00 price objective ...
Rezolute, Inc.: Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Open-label arm (infant participants DMC approved enrollment of infants into the double-blind portion of the study sunRIZE enrollment completion expected in Q2 2025, subject to outcomes from upcoming ...
Rezolute's ersodetug advances in pediatric study
REDWOOD CITY, Calif. - Rezolute , Inc. (NASDAQ:RZLT), a biopharmaceutical company with a market capitalization of $303.62 million and impressive recent momentum (up 13.91% in the past week), announced ...
manilatimes10d
H&R Block and Peoples Group announce new partnership to deliver H&R Block Advantage Prepaid Mastercard
Peoples Group is thrilled to announce an exciting new partnership with H&R Block Canada, supporting their ongoing delivery of ...
Yahoo Finance14d
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
Rezolute, Inc. REDWOOD CITY, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to ...
Taiwan News14d
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
REDWOOD CITY, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative ...
Mena FN14d
Rezolute To Participate In The Guggenheim SMID Cap Biotech Conference
(MENAFN- GlobeNewsWire - Nasdaq) REDWOOD CITY, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the“Company”), a late ...